[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8609351A1 - Hydrosoluble antibiotic pharmaceutical compositions - Google Patents

Hydrosoluble antibiotic pharmaceutical compositions

Info

Publication number
ES8609351A1
ES8609351A1 ES547625A ES547625A ES8609351A1 ES 8609351 A1 ES8609351 A1 ES 8609351A1 ES 547625 A ES547625 A ES 547625A ES 547625 A ES547625 A ES 547625A ES 8609351 A1 ES8609351 A1 ES 8609351A1
Authority
ES
Spain
Prior art keywords
hydrosoluble
pharmaceutical compositions
antibiotic pharmaceutical
antibiotic
salified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547625A
Other languages
Spanish (es)
Other versions
ES547625A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Original Assignee
Schering SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA filed Critical Schering SpA
Publication of ES547625A0 publication Critical patent/ES547625A0/en
Publication of ES8609351A1 publication Critical patent/ES8609351A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
    • C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The compositions contain salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids e.g. arginine, ornithine, lysine, or cysteine and are characterised by containing an excess of a not salified aminoacid.
ES547625A 1984-10-05 1985-10-04 Hydrosoluble antibiotic pharmaceutical compositions Expired ES8609351A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4792/84A CH660306A5 (en) 1984-10-05 1984-10-05 WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS BASED ON SALTS OF (-)CIS-1,2-EPOXYPROPYLPHOSPHONIC ACID WITH AMINO ACIDS.

Publications (2)

Publication Number Publication Date
ES547625A0 ES547625A0 (en) 1986-09-01
ES8609351A1 true ES8609351A1 (en) 1986-09-01

Family

ID=4282621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547625A Expired ES8609351A1 (en) 1984-10-05 1985-10-04 Hydrosoluble antibiotic pharmaceutical compositions

Country Status (11)

Country Link
JP (1) JPS62223121A (en)
KR (1) KR860003012A (en)
AT (1) AT383736B (en)
BE (1) BE903369A (en)
CH (1) CH660306A5 (en)
DE (1) DE3535356A1 (en)
ES (1) ES8609351A1 (en)
FR (1) FR2571255B1 (en)
GB (1) GB2165152B (en)
IT (1) IT1201479B (en)
NL (1) NL8502712A (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH310498A (en) * 1951-11-14 1955-10-31 Waldhof Zellstoff Fab Process for stabilizing alkali salts of adenosine polyphosphoric acids.
DE1767212B1 (en) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Process for making injectable drugs
US3639590A (en) * 1967-07-25 1972-02-01 Merck & Co Inc Antibacterial composition containing (-) (cis-1 2-epoxypropyl) phosphoric acid
BE756953A (en) * 1969-10-02 1971-04-01 Merck & Co Inc POTENTIALIZATION OF ANTIBIOTICS
IT1161974B (en) * 1978-02-02 1987-03-18 Italchemi Spa CIS.I 2 EPOXYPROPYLPHOSPHONIC ACID DERIVATIVES THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE2813814A1 (en) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Increasing the enteral reabsorption of pharmaceuticals - by administration together with an aminoacid or a peptide
IT1112282B (en) * 1978-07-19 1986-01-13 Zambon Spa Bis- (2-AMMONIUM-2-hydroxymethyl-1,3-propanediol) (2R-CIS) - (3-METILOSSIRANIL) phosphonate
IT1097578B (en) * 1978-07-31 1985-08-31 Italchemi Spa METHOD FOR PREPARING ACID SALTS (-)
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions

Also Published As

Publication number Publication date
IT8522367A0 (en) 1985-10-04
ATA287185A (en) 1987-01-15
GB8524550D0 (en) 1985-11-06
GB2165152A (en) 1986-04-09
GB2165152B (en) 1988-03-16
FR2571255B1 (en) 1988-09-16
BE903369A (en) 1986-02-03
IT1201479B (en) 1989-02-02
NL8502712A (en) 1986-05-01
AT383736B (en) 1987-08-10
DE3535356A1 (en) 1986-04-24
FR2571255A1 (en) 1986-04-11
ES547625A0 (en) 1986-09-01
JPS62223121A (en) 1987-10-01
KR860003012A (en) 1986-05-19
CH660306A5 (en) 1987-04-15

Similar Documents

Publication Publication Date Title
ES8801930A1 (en) N,N-dialkylguanidino dipeptides.
EP0341966A3 (en) Homogeneous mammalian hematopoietic stem cell composition
IE45390L (en) Anti-caries composition
JPS52116465A (en) Peptides
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
MX172918B (en) L-3,4-DIHYDROXYPHENYLALANINE BASED COMPOSITION
ES2014060A6 (en) Pharmaceutical compositions acting on the heart and cardiovascular system
CA2015186A1 (en) Nutrient composition
GB2181647B (en) Compositions based on lysine and arginine salts.
ATE63750T1 (en) PEPTIDE, ITS PRODUCTION AND USE.
JPS5486635A (en) First liquid of cold-wave lotion
ES8407011A1 (en) Derivatives of A-21978C cyclic peptides
ES8609351A1 (en) Hydrosoluble antibiotic pharmaceutical compositions
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
ES8608861A1 (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
GB1051686A (en)
AU544742B2 (en) Prepare amides especially peptides
JPS6463342A (en) Stabilization of glutathione-containing composition
ES8703847A1 (en) Sulfonyl-guanidinopyrimidine derivatives.
ES2000182A6 (en) Growth-promoting agent.
ES8606259A1 (en) L-arginine isoxicamate.
ES8308832A1 (en) Fluorinated diamino-heptene and -heptyne derivatives.
ES2001042A6 (en) Process for the preparation of 5,6-dialkoxyanthranilic acids.
ES476430A1 (en) Novel peptide type antibiotic and the process for the production thereof
ES8606248A1 (en) Process for the preparation of optically active glycine derivatives.